Chemistry and immunoassay testing system reagents and supplies
Ended Awarded Last action
- Contract number
- HT941025FE029
- Awardee
-
Ortho Clinical Diagnostics K.K. UEI E35NFBSEY3X4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $19,443
Award facts
- Contract value 100% obligated
- $19,443.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Japan
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $19,443.19 firm fixed-price Blanket Purchase Agreement call to Ortho Clinical Diagnostics K.K. on September 4, 2025, for chemistry and immunoassay testing system reagents and supplies. The work will be performed in Japan with an ultimate completion date of September 15, 2025. This call is issued under a larger $2.875M single-award BPA established July 1, 2024, through June 30, 2029, for VITROS 7600 laboratory testing equipment consumables supporting U.S. military medical facilities throughout Japan, including Yokota Air Base and other installations. The award does not include a socioeconomic set-aside designation.
Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global in vitro diagnostics provider Ortho Clinical Diagnostics, is the established primary supplier of laboratory diagnostic materials to Defense Health Agency and Department of Navy medical facilities throughout the Indo-Pacific region. The company maintains substantial existing contract relationships with the Defense Health Agency, Department of Navy Bureau of Medicine and Surgery, and Pacific Air Forces, including a $4.85M sole-source contract for VITROS XT7600 reagents and consumables at U.S. Naval Hospital Yokosuka through September 2027 and a $2.53M BPA with Pacific Air Forces for clinical laboratory chemistry and immunoassay testing systems. This call continues the company's extensive support of critical laboratory diagnostic operations at U.S. military naval hospitals, air force bases, and medical research centers in Japan.
Quick answers
Who was awarded contract HT941025FE029?
HT941025FE029 was awarded to Ortho Clinical Diagnostics K.K. by Defense Health Agency (Department of Defense) on September 4, 2025.
How much is contract HT941025FE029 worth?
The government has obligated $19,443 on HT941025FE029.
Is contract HT941025FE029 an order under another contract?
Yes. HT941025FE029 is a BPA call under HT941024A0007, a blanket purchase agreement.
Was contract HT941025FE029 competed?
The extent of competition for HT941025FE029 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award